US2021259587A1PendingUtilityA1

Analyte sensor

Assignee: DEXCOM INCPriority: Aug 1, 2003Filed: May 10, 2021Published: Aug 26, 2021
Est. expiryAug 1, 2023(expired)· nominal 20-yr term from priority
C12Q 1/001G16H 20/17A61M 2005/14296A61B 5/7275A61M 5/14232A61B 5/155G16H 40/40A61B 2560/04A61B 2562/085A61B 5/0031G16H 10/40A61B 5/1486A61B 5/14503A61M 2230/201A61B 5/15003A61B 5/7221A61B 5/746A61B 5/14535A61B 5/157A61M 5/14A61B 5/4839A61B 5/6849A61B 2560/0223A61B 5/14542A61M 5/1723A61B 5/150992A61B 5/14532A61B 5/6866A61B 5/6848A61B 5/14865A61B 2560/0252C12Q 1/006A61B 5/14539A61B 5/14546A61B 5/743G16H 40/63A61B 5/1495A61B 5/14735Y02A90/10A61B 5/412A61M 5/16804
77
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

Claims

exact text as granted — not AI-modified
1 - 18 . (canceled) 
     
     
         19 . A system for measuring an analyte concentration in a host, the system comprising:
 a transcutaneous analyte sensor; and   sensor electronics configured to operatively connect to the transcutaneous analyte sensor.   
     
     
         20 . A method for processing data from a transcutaneous analyte sensor, the method comprising:
 receiving sensor data indicative of an analyte concentration in the host; and   processing, using a processor, the sensor data.

Join the waitlist — get patent alerts

Track US2021259587A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.